Bone marrow transplantation for chronic myeloid leukaemia: The effects of differing criteria for defining chronic phase on probabilities of survival and relapse

British Journal of Haematology

Volumn 99, Issue 1, 1997, Pages 30-35

  Savage, David G ^a,b   Szydlo, Richard M ^a   Chase, Andrew ^a   Apperley, Jane F ^a   Goldman, John M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

Bone marrow transplantation; Chronic myeloid leukaemia; Will Rogers phenomenon

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME;

EID: 0030831669     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.3453159.x     Document Type: Article

References (30)

1. Apperley, J.F., Mauro, F.R., Goldman, J.M., Gregory, W., Arthur, C.K., Hows, J., Arcese, W., Papa, G., Mandelli, F., Wardle, D., Franklin, I.M., Bandini, G., Ricci, P., Tura, S., Iacone, A., Torlontano, G., Heit, W., Champlin, R. & Gale, R.P. (1988) Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effect. British Journal of Haematology, 69, 239-245.
2. Biggs, J.C., Horowitz, M.M., Gale, R.P., Ash, R.C., Atkinson, K., Helbig, W., Jacobsen, N., Phillips, G.L., Rimm, A.A., Ringdén, O., Rozman, C., Sobocinski, K.A., Veum, J.A. & Bortin, M.M. (1992) Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy. Blood, 80, 1090-1093.
3. Bortin, M.M., Gale, R.P. & Rimm, A.A., for the Advisory Committee of the International Bone Marrow Registry (1981) Allogeneic bone marrow transplantation for 144 patients with severe aplastic anemia. Journal of the American Medical Association, 245, 1132-1139.
4. Clift, R.A., Buckner, C.D., Appelbaum, F.R., Bearman, S.I., Petersen, F.B., Fisher, L.D., Anasetti, C., Beatty, P., Bensinger, W.I., Doney, K., Hill, R.S., McDonald, G.B., Martin, P., Sanders, J., Singer, J., Stewart, P., Sullivan, K.M., Witherspoon, R.P., Storb, R., Hansen, J.A. & Thomas, E.D. (1990) Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trail of two irradiation regimens. Blood, 76, 1867-1871.
5. Clift, R.A., Buckner, C.D., Appelbaum, F.R., Bearman, S.I., Petersen, F.B., Fisher, L.D., Anasetti, C., Beatty, P., Bensinger, W.I., Doney, K., Hill, R.S., McDonald, G.B., Martin, P., Sanders, J., Singer, J., Stewart, P., Sullivan, K.M., Witherspoon, R., Storb, R., Hansen, J.A. & Thomas, E.D. (1991) Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens. Blood, 77, 1660-1665.
6. Clift, R.A., Buckner, C.D., Thomas, E.D., Bryant, E., Anasetti, C., Bensinger, W.I., Bowden, R., Deeg, H.J., Doney, K.C., Fisher, L.D., Hansen, J.A., Martin, P., McDonald, G.B., Sanders, J.K., Schoch, G., Singer, J., Storb, R., Sullivan, K.M., Witherspoon, R.P. & Appelbaum, F.R. (1994) Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia. Blood, 84, 4368-4373.
7. Clift, R.A., Buckner, C.D., Thomas, E.D., Kopecky, K.J., Appelbaum, F.R., Tallman, M., Storb, R., Sanders, J., Sullivan, K., Banaji, M., Beatty, P.S., Bensinger, W., Cheever, M., Deeg, J., Doney, K., Fefer, A., Greenberg, P., Hansen, J.A., Hackman, R., Hill, R., Martin, P., Meyers, J., McGuffin, R., Neiman, P., Sale, G., Shulman, H., Singer, J., Stewart, P., Weiden, P. & Witherspoon, R. (1987) The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation. Bone Marrow Transplantation, 2, 243-258.
8. Deeg, H.J., Spitzer, T.R., Cottler-Fox, M., Cahill, R. & Pickle, L.W. (1991) Conditioning-related toxicity and acute graft-versus-host disease in patients given methotrexate/cydosporine prophylaxis. Bone Marrow Transplantation, 7, 193-198.
9. Devergie, A., Blaise, D., Attal, M., Tigaud, J.D., Jouet, J.P., Vernant, J.P., Bordigoni, P., Ifrah, N., Dauriac, C., Cahn, J.Y., Lioure, B., Troussard, X., Reiffers, J., Gratecos, N., Milpied, N., Belanger, C., Guyotat, D., Tilly, H., Michallet, M. & Gluckman, E. (1995) Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trail of busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from The French Society of Bone Marrow Graft (SFGM). Blood, 85, 2263-2268.
10. Doney, K.C., Buckner, C.D., Thomas, E.D., Sanders, J., Clift, R.A., Hansen, J.A., Sale, G.E., Singer, J. & Storb, R. (1981) Allogeneic bone marrow transplantation for chronic granulocytic leukemia. Experimental Hematology, 9, 966-971.
11. Feinstein, A.R., Sosin, D.M. & Wells, C.K. (1985) The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. New England Journal of Medicine, 312, 1604-1608.
12. Goldman, J.M., Apperley, J.F., Jones, L., Marcus, R., Goolden, A.W.G., Batchelor, R., Hale, G., Waldmann, H., Reid, C.D., Hows, J., Gordon-Smith, E., Catovsky, D. & Galton, D.A.G. (1986) Bone marrow transplantation for patients with chronic myeloid leukemia. New England Journal of Medicine, 314, 202-207.
13. Goldman, J.M., Gale, R.P., Horowitz, M.M., Biggs, J.C., Champlin, R.E., Gluckman, E., Hoffmann, R.G., Jacobsen, S.J., Marmont, A.M., McGlave, P.B., Messner, H.A., Rimm, A.A., Rozman, C., Speck, B., Tura, S., Weiner, R.S. & Bortin, M.M. (1988) Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk of relapse associated with T-cell depletion. Annals of Internal Medicine, 108, 806-814.
14. Hermanek, P. (1996) Will Rogers phenomenon: fact or fiction. Chirurgie, 67, 769-770.
15. Hermanek, P. & Wittekind, C. (1994) Residual tumor classification and prognosis. Seminars in Surgical Oncology, 10, 12-20.
16. Kantarjian, H.M., Keating, M.J., Smith, T.L., Talpaz, M. & McCredie, K.B. (1990) Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemia. American Journal of Medicine, 88, 1-8.
17. Kaplan, E.L. & Meier, P. (1976) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457-481.
18. Karanas, A. & Silver, R.T. (1968) Characteristics of the terminal phase of chronic granulocytic leukemia. Blood, 32, 445-459.
19. Marks, D.I., Cullis, J.O., Ward, K.N., Szydlo, R., Hughes, T.P., Barrett, A.J., Hows, J.M., Batchelor, J.R. & Goldman, J.M. (1993) Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors: a comparison of complications in the first two years. Annals of Internal Medicine, 119, 207-214.
20. Marmont, A.M., Horowitz, M.M., Gale, R.P., Sobocinski, K., Ash, R.C., van Bekkum, D.W., Champlin, R.E., Dicke, K.A., Goldman, J.M., Good, R.A., Herzig, R.H., Hong, R., Masaoka, T., Rimm, A.A., Ringdén, O., Speck, B., Weiner, R.S. & Bortin, M.M. (1991) T-cell depletion of HLA-identical transplants in leukemia. Blood, 78, 2120-2130.
21. Martin, P.J., Clift, R.A., Fisher, L.D., Buckner, C.D., Hansen, J.A., Appelbaum, F.R., Doney, K.C., Sullivan, K.M., Witherspoon, R.P., Storb, R. & Thomas, E.D. (1988) HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration. Blood, 72, 1978-1984.
22. Nash, R.A., Pepe, M.S., Storb, R., Longton, G., Pettinger, M., Anasetti, C., Appelbaum, F.R., Bowden, R.A., Deeg, H.J., Doney, K., Martin, P.J., Sullivan, K.M., Sanders, J. & Witherspoon, R.P. (1992) Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood, 80, 1838-1845.
23. Peckham, M.J., Ford, H.T., McElwain, T.J., Harmer, C.L., Atkinson, K. & Austin, D.E. (1975) The results of radiotherapy for Hodgkin's disease. British Journal of Cancer, 32, 391-400.
24. Savage, D.G., Szydlo, R.M. & Goldman, J.M. (1997) Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16-year period. British Journal of Haematology, 96, 111-116.
25. Speck, B., Bortin, M.M., Champlin, R., Goldman, J.M., Herzig, R.H., McGlave, P.B., Messner, H.A., Weiner, R.S. & Rimm, A.A. (1984) Allogeneic bone marrow transplantation for chronic myelogenous leukaemia. Lancet, i, 665-668.
26. Spiers, A.S.D. (1979) Metamorphosis of chronic granulocytic leukaemia: diagnosis, classification, and management. British Journal of Haematology, 41, 1-7.
27. Theologides, A. (1972) Unfavorable signs in patients with chronic myelocytic leukemia. Annals of Internal Medicine, 76, 95-99.
28. Thomas, E.D., Clift, R.A., Fefer, A., Appelbaum, F.R., Beatty, P., Bensinger, W.I., Buckner, C.D., Cheever, M.A., Deeg, H.J., Doney, K., Flournoy, N., Greenberg, P., Hansen, J.A., Martin, P., McGuffin, R., Ramberg, R., Sanders, J.E., Singer, J., Stewart, P., Storb, R., Sullivan, K., Weiden, P.L. & Witherspoon, R. (1986) Marrow transplantation for the treatment of chronic myelogenous leukemia. Annals of Internal Medicine, 104, 155-163.
29. Thomas, E.D., Storb, R., Clift, RA., Fefer, A., Johnson, L., Neiman, P.E., Lerner, K.G., Glucksberg, H. & Buckner, C.D. (1975) Bone marrow transplantation (Part 2). New England Journal of Medicine, 292, 895-902.
30. Trasti, H. & Hoel, S. (1985) The Will Rogers phenomenon: additional evidence. New England Journal of Medicine, 313, 1291.